[사회]Vaccine supply in Europe… is there any disruption in domestic introduction?

[앵커]

As the supply of Corona 19 vaccines in Europe is disrupted, there are signs of a vaccine crisis, such as governments of various countries foretelling lawsuits against manufacturers.

Contrary to this European situation, the Korean government has announced that it will not be disrupted because it plans to first receive domestically produced vaccines.

Reporter Lee Dong-woo reports.

[기자]

In recent years, the supply of AstraZeneca vaccine has been significantly delayed in Europe following Pfizer.

In particular, AstraZeneca decided to supply 80 million doses of vaccine to 27 countries in Europe by the first quarter of this year, but 60% of the vaccine is expected to be difficult to supply.

A major fire broke out in a production facility in India, and the vaccine was adjusted for mutant viruses originating in the UK and South Africa, disrupting the supply.

[권준욱 / 중앙방역대책본부 제2부본부장 : 거기에 치료제와 백신도 도전에 직면해 있습니다. 조사 분석 중이긴 합니다만 최악의 경우에는 효과에 대해서 문제가 생길 가능성도 배제할 수는 없습니다.]

For this reason, European countries that were unable to secure vaccine quantities have announced a lawsuit against manufacturers.

There is also a situation of concern even for a vaccine crisis.

However, the Korean government said there was no problem with the domestic vaccine supply and demand plan.

[손영래 / 중앙사고수습본부 사회전략반장 : 일단 현재까지는 백신 공급에 있어서 별도의 차질이 있다고 하는 연락들을 받지는 못했습니다. 따라서 현재까지는 일정대로 공급이 될 것이라고 판단하고 있으며….]

Currently, in Korea, SK Bioscience is consigning vaccines for AstraZeneca and NovaVax, and it is explained that there will be no setbacks as it will receive this supply.

On the 28th, the government will announce the implementation plan for the corona19 vaccination, including the current status of the vaccine introduction, priority targets, and preparations.

Currently, the government has secured 56 million vaccines, including AstraZeneca, and has a contract with NovaVax to introduce an additional 20 million vaccines.

The first vaccine that comes in next month is Pfizer’s 50,000 vaccine, and it is expected that medical staff and elderly people in nursing homes will receive the vaccine first.

The government plans to form collective immunity before this winter by vaccinating 70% of the population by November.

This is YTN Lee Dong-woo.

※’Your report becomes news’ YTN is waiting for your valuable report.
[카카오톡] Search YTN to add a channel [전화] 02-398-8585 [메일] [email protected] [온라인 제보] www.ytn.co.kr

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

– .